Versant Venture Capital VI, L.P. 13D and 13G filings for Oyster Point Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-13 4:09 pm Sale |
2023-01-03 | 13D | Oyster Point Pharma, Inc. OYST |
Versant Venture Capital VI, L.P. | 0 0.000% |
-2,236,888 (Position Closed) |
Filing |
| 2022-01-13 4:34 pm Unchanged |
2022-01-05 | 13D | Oyster Point Pharma, Inc. OYST |
Versant Venture Capital VI, L.P. | 2,236,888 8.500% |
0 (Unchanged) |
Filing |
| 2021-10-27 4:32 pm Unchanged |
2021-10-18 | 13D | Oyster Point Pharma, Inc. OYST |
Versant Venture Capital VI, L.P. | 2,236,888 8.600% |
0 (Unchanged) |
Filing |
| 2021-05-24 4:27 pm Unchanged |
2021-05-12 | 13D | Oyster Point Pharma, Inc. OYST |
Versant Venture Capital VI, L.P. | 2,236,888 8.600% |
0 (Unchanged) |
Filing |
| 2021-04-05 4:33 pm Unchanged |
2021-03-26 | 13D | Oyster Point Pharma, Inc. OYST |
Versant Venture Capital VI, L.P. | 2,236,888 8.600% |
0 (Unchanged) |
Filing |
| 2021-03-01 5:16 pm Sale |
2021-02-17 | 13D | Oyster Point Pharma, Inc. OYST |
Versant Venture Capital VI, L.P. | 2,236,888 8.600% |
-325,000 (-12.69%) |
Filing |